The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-Fluorophenyl)-4-(6-(4-(4-methylpiperazin-1-yl)-phenyl)thieno[2,3-d]pyrimidin-4-yl)piperazine-1-carboxamide ID: ALA4858075
PubChem CID: 164610912
Max Phase: Preclinical
Molecular Formula: C28H30FN7OS
Molecular Weight: 531.66
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccccc6F)CC5)ncnc4s3)cc2)CC1
Standard InChI: InChI=1S/C28H30FN7OS/c1-33-10-12-34(13-11-33)21-8-6-20(7-9-21)25-18-22-26(30-19-31-27(22)38-25)35-14-16-36(17-15-35)28(37)32-24-5-3-2-4-23(24)29/h2-9,18-19H,10-17H2,1H3,(H,32,37)
Standard InChI Key: VTQFSAWJAUSJLB-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
16.4883 -29.0887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7825 -29.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7825 -30.3227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4919 -30.7313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2013 -30.3227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2013 -29.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4919 -31.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7780 -31.9598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7780 -32.7804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4901 -33.1939 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2011 -32.7746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2011 -31.9576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9765 -31.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4591 -32.3592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9859 -33.0203 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.2773 -32.3592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6945 -33.0656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5151 -33.0656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9194 -32.3448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5013 -31.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6821 -31.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7365 -32.3365 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1465 -33.0397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9601 -33.0334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3654 -32.3234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9509 -31.6180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1311 -31.6227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1826 -32.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4865 -28.2715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1932 -27.8613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7778 -27.8645 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9019 -28.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8989 -29.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6067 -29.4926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3144 -29.0824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3100 -28.2609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6016 -27.8577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5962 -27.0405 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 1 1 0
4 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
12 11 2 0
12 7 1 0
13 12 1 0
14 13 2 0
15 14 1 0
11 15 1 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
1 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
37 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 531.66Molecular Weight (Monoisotopic): 531.2217AlogP: 4.60#Rotatable Bonds: 4Polar Surface Area: 67.84Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.42CX Basic pKa: 7.84CX LogP: 4.72CX LogD: 4.14Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.42Np Likeness Score: -2.09
References 1. Li Y, Yang G, Zhang J, Tang P, Yang C, Wang G, Chen J, Liu J, Zhang L, Ouyang L.. (2021) Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer., 64 (16.0): [PMID:34351741 ] [10.1021/acs.jmedchem.1c00678 ]